Xiaoming D. Jia

Neurology
400 Parnassus Ave
San Francisco, CA 94143

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

Emerging Cerebrospinal Fluid Biomarkers of Disease Activity and Progression in Multiple Sclerosis.

Emerging Cerebrospinal Fluid Biomarkers of Disease Activity and Progression in Multiple Sclerosis.

Journal: JAMA neurology
Published: March 11, 2024

Adaptive and Innate Immunity Are Key Drivers of Age at Onset of Multiple Sclerosis.

Adaptive and Innate Immunity Are Key Drivers of Age at Onset of Multiple Sclerosis.

Journal: Neurology. Genetics
Published: December 04, 2023

Blood neurofilament light levels predict non-relapsing progression following anti-CD20 therapy in relapsing and primary progressive multiple sclerosis: findings from the ocrelizumab randomised, double-blind phase 3 clinical trials.

Blood neurofilament light levels predict non-relapsing progression following anti-CD20 therapy in relapsing and primary progressive multiple sclerosis: findings from the ocrelizumab randomised, double-blind phase 3 clinical trials.

Journal: EBioMedicine
Published: March 09, 2023

Genome-wide study of longitudinal brain imaging measures of multiple sclerosis progression across six clinical trials.

Genome-wide study of longitudinal brain imaging measures of multiple sclerosis progression across six clinical trials.

Journal: Scientific reports
Published: March 07, 2023

Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity.

Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: January 12, 2023

Multi-arm U-Net with dense input and skip connectivity for T2 lesion segmentation in clinical trials of multiple sclerosis.

Multi-arm U-Net with dense input and skip connectivity for T2 lesion segmentation in clinical trials of multiple sclerosis.

Journal: Scientific reports
Published: November 08, 2022

Joint MRI T1 Unenhancing and Contrast-enhancing Multiple Sclerosis Lesion Segmentation with Deep Learning in OPERA Trials.

Joint MRI T1 Unenhancing and Contrast-enhancing Multiple Sclerosis Lesion Segmentation with Deep Learning in OPERA Trials.

Journal: Radiology
Published: December 14, 2021

Deformation-based morphometry identifies deep brain structures protected by ocrelizumab.

Deformation-based morphometry identifies deep brain structures protected by ocrelizumab.

Journal: NeuroImage. Clinical
Published: November 01, 2021

Development of an age-adjusted model for blood neurofilament light chain.

Development of an age-adjusted model for blood neurofilament light chain.

Journal: Annals of clinical and translational neurology
Published: July 27, 2021

Correction: Investigating rare pathogenic/likely pathogenic exonic variation in bipolar disorder.

Correction: Investigating rare pathogenic/likely pathogenic exonic variation in bipolar disorder.

Journal: Molecular psychiatry
Published: March 06, 2021

Exome sequencing in bipolar disorder identifies AKAP11 as a risk gene shared with schizophrenia.

Exome sequencing in bipolar disorder identifies AKAP11 as a risk gene shared with schizophrenia.

Journal: Nature genetics
Published: March 03, 2021

Accurate imputation of human leukocyte antigens with CookHLA.

Accurate imputation of human leukocyte antigens with CookHLA.

Journal: Nature communications
Published: May 21, 2020
Showing 1-12 of 20

Last Updated: 09/26/2026